This grant opportunity funds clinical trials research under four streams: pilot studies for rare diseases, clinical trials for rare cancers and unmet needs, trials addressing evidence gaps for health technology assessments, and prevention trials targeting early intervention. The goal is to enhance evidence-based healthcare and patient access to innovative treatments in Australia.
Only approved MRFF Eligible Organisations can apply. Applicants must meet all requirements outlined in the 2026 Clinical Trials Activity Grant Opportunity Guidelines.
